Jazz Pharmaceuticals’s employee count changed from 2.80K in Dec 2024 to 2.89K in Dec 2025 increasing 3.2% in this time period....
Endo Competitors or Alternatives
Endo's top competitors include Viatris, Jazz Pharmaceuticals and Takeda Pharmaceutical.
Endo VS Viatris
Viatris is Endo's top competitor. Viatris was founded in 2020 in Canonsburg, Pennsylvania. Viatris competes in the Pharmaceuticals field. Viatris generates $13.1B more revenue than Endo.
Endo VS Jazz Pharmaceuticals
Jazz Pharmaceuticals is perceived as one of Endo's biggest rivals. Jazz Pharmaceuticals's headquarters is in Dublin, County Dublin, and was founded in 2003. Like Endo, Jazz Pharmaceuticals also competes in the Pharmaceuticals industry. Jazz Pharmaceuticals generates 362% of Endo's revenue.
Endo VS Takeda Pharmaceutical
Takeda Pharmaceutical is one of Endo's top competitors. Takeda Pharmaceutical is a Public company that was founded in Tokyo, Tōkyō Prefecture in 1781. Like Endo, Takeda Pharmaceutical also competes in the Pharmaceuticals field. Takeda Pharmaceutical has 44,339 more employees vs. Endo.
Looking for similar companies to Endo?
Similar Companies
Pharmaceuticals companies in Malvern
See 19 companies
Companies in Delaware Valley with revenue in $1.0-5.0B rangeSee 135 companies
Pharmaceuticals & Biotechnology companies in MalvernSee 38 companies
Pharmaceuticals companies with revenue in $1.0-5.0B rangeSee 148 companies
Companies in Pennsylvania with revenue in $1.0-5.0B rangeSee 174 companies
Pharmaceuticals companies with employees in 1.0-5.0K rangeSee 203 companies
Pharmaceuticals & Biotechnology companies with revenue in $1.0-5.0B rangeSee 206 companies
Companies in Delaware Valley with employees in 1.0-5.0K rangeSee 298 companies
Companies in Pennsylvania with employees in 1.0-5.0K rangeSee 392 companies
Trending News for Endo and Endo's Competitors
ABBV's neuroscience unit delivered $10.8B in 2025 and can hit $12.5B in 2026 as Vyalev gains traction and new Parkinson's drug tavapadon awaits FDA rev...
(RTTNews) - Bristol Myers Squibb (BMY) announced that the U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of...
Alnylam Pharmaceuticals has forged a discovery collaboration worth up to $1.23bn with cardiovascular disease specialist, Tenaya Therapeutics. Through t...
The qualitative latest Research report (2026-2033) on the Melanoma Diagnostic and Therapeutic Market by Coherent Market Insights Provides a deep dive i...
BioMarin’s employee count changed from 3.04K in Dec 2024 to 3.22K in Dec 2025 increasing 6.0% in this time period....
The US state investment will go to 33 community-based organisations...
Gilead Sciences’s employee count changed from 17.60K in Dec 2024 to 17K in Dec 2025 decreasing 3.4% in this time period....
BioMarin Pharmaceutical has been the subject of recent discussions on an online forum, according to a thread posted on March 7, 2026. The thread, hoste...
Frequently Asked Questions about Endo
Who are Endo's top competitors?
Endo's top 3 competitors are Viatris, Jazz Pharmaceuticals, Takeda Pharmaceutical.Who is similar to Endo?
Viatris is the most similar to Endo. Jazz Pharmaceuticals and Takeda Pharmaceutical are also similar to Endo.
Are Endo and Viatris competitors?
Yes, Viatris is one of Endo’s top competitors.